isomethyleugenol has been researched along with Smooth Muscle Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, A; Lee, V; Ong, D; Ong, KW; Tan, CS; Teo, M; Toh, HC; Vathsala, A | 1 |
1 other study(ies) available for isomethyleugenol and Smooth Muscle Tumor
Article | Year |
---|---|
Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
Topics: Adult; Antigens, Viral; Apoptosis Regulatory Proteins; Cell Line, Tumor; Epstein-Barr Virus Infections; Female; Glutathione S-Transferase pi; Herpesvirus 4, Human; Humans; Kidney Transplantation; Male; Methylation; Middle Aged; Promoter Regions, Genetic; Protein Kinases; Proto-Oncogene Proteins c-akt; Receptors, Retinoic Acid; Ribosomal Protein S6 Kinases, 70-kDa; Smooth Muscle Tumor; TOR Serine-Threonine Kinases; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A | 2009 |